Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
Voice-First Clinical Notes In Healthcare: Benefits And Use Cases
Clinicians spend roughly half their day in EHRs and additional hours after hours completing notes. Voice‑first documentation tools—live dictation, back‑end transcription, and ambient AI scribing—promise to reclaim that time without compromising record quality. Studies show ambient scribing can reduce note‑writing time by 15% and after‑hours charting by 18% after several months. Successful adoption hinges on tight EHR integration, HIPAA‑compliant privacy safeguards, and small‑scale pilots before broader rollout.
AP Report Finds 10 ICE Detainee Suicides Since 2025, Highlighting Mental‑Health Gaps
An Associated Press investigation uncovered ten suicides among ICE detainees since January 2025, with seven occurring after October and representing the highest fiscal‑year tally on record. Experts say the spike signals systemic failures in mental‑health care and oversight within immigration...
Hansa Biopharma’s Idefirix Hits 90% Graft Survival in EU Post‑Authorization Study
Hansa Biopharma announced that its gene‑therapy desensitization product Idefirix met the primary endpoint of a European post‑authorization study, delivering 90% one‑year graft failure‑free survival in highly sensitized kidney‑transplant patients. The results also showed 92% graft survival and 98% patient survival,...
Embryos Made without Sperm or Eggs Reveal Why Many Pregnancies Fail
Scientists in Vienna have created embryo organoids, called blastoids, entirely from stem cells without sperm or eggs. These models replicate the structure and early gene activity of a natural blastocyst, allowing researchers to observe implantation and other first‑week events in...
Antiviral Valganciclovir Extends GBM Survival to 5 Years
🧠 GBM patients on continuous valganciclovir survived 56.4 months — nearly 5 years — vs. the typical 12–15. Years ago, Thomas Seyfried told me that CMV damages mitochondria and drives tumor initiation and growth. This NEJM study validated that insight in a...
Inside Optum Health's Push to Make AI Practical for Clinicians
Optum Health piloted an AI‑driven chart summarization tool to cut clinicians' after‑hours record‑review time. The feature automatically condenses patient histories into a concise view, letting providers prepare faster before appointments. Early results showed smoother visit flow, reduced documentation workload, and...
Technology Needs Meet Enterprise Goals to Support a Care Continuum
Apple’s VP of health and fitness, Sumbul Ahmad Desai, emphasized at the 2026 HIMSS conference that technology must address real clinical problems, not exist for its own sake. She highlighted Apple’s evolution of wearables toward clinically validated data that supports...
Resident Doctors in England to Strike for 16th Time over Pay
Resident doctors in England will stage their 16th strike from June 15 to June 19, after Health Secretary James Murray signaled no willingness to negotiate further pay. Over the past four years doctors have received a cumulative 33% pay rise,...
Diabetes Drugs Improve Survival for Patients with ‘Broken Hearts’
Early administration of sodium‑glucose cotransporter‑2 (SGLT2) inhibitors was linked to a lower all‑cause mortality rate in patients with Takotsubo syndrome, a condition often dubbed “broken‑heart syndrome.” The real‑world analysis examined nearly 55,000 TTS cases from 2015‑2025, propensity‑matching 1,803 patients who...
DSH Hospital System Has Little Money to Invest in AI
USA Health, a three‑hospital Disproportionate Share system in Mobile, Alabama, faces razor‑thin margins that limit AI investment in its revenue cycle. Chief revenue officer Candice Powers says the hospital must prioritize affordable, ROI‑driven tools and has begun embedding AI into...
Virchow Medical Strengthens Scientific Advisory Board with New Appointments
Virchow Medical announced that Dr. William Morice, CEO of Mayo Clinic Laboratories, has joined its Scientific Advisory Board, and that Khosrow Shotorbani, founder of Clinical Lab 2.0, has moved from the Market Outreach board to the SAB. The company also held...
Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting
Junevity will present pioneering in‑vivo data showing an siRNA therapeutic can restore global gene networks to a healthier state. Co‑founder Dr. Janine Sengstack will share results from diabetic mouse studies and safety data in rats and non‑human primates, marking the...
Inside Tom: Lumeris Is Quietly Building Primary Care’s Operating System
Lumeris is quietly constructing an AI‑driven operating system for primary care called Tom. Leveraging a deep partnership with Google Cloud, Tom delivers agentic capabilities such as Native Audio and proactive patient outreach on a two‑to‑three‑week release cadence. The platform’s Hawkeye...
How RFID-Enabled Mira Care Can Bolster Hospital Cold Storage Resilience
Intelliguard and Accucold have introduced the RFID‑enabled Mira Care inventory cabinet, embedding Intelliguard’s medication tracking platform into Accucold’s Pharma‑Vac refrigerated units. The system delivers real‑time visibility of temperature, expiration dates, recall exposure, user access and inventory movement. It arrives amid...
Top-Paying State for 15 Physician Specialties
Becker’s analysis, using May 2025 BLS wage data and cost‑of‑living indices, identifies the highest‑paying states for 15 physician specialties after adjusting for regional price differences. Minnesota emerges as the top‑paying state for four specialties—anesthesiology, dermatology, neurology and radiology—while Missouri, West...
Coalition for Health AI (CHAI) Launches In-Depth Governance Playbooks for 100+ Health Systems
The Coalition for Health AI (CHAI) has launched a series of in‑depth governance playbooks aimed at establishing baseline controls for safe, transparent AI deployment across more than 100 health systems. Developed by over 150 industry leaders, the open‑source guides map...
The Country’s Newest Medical Schools: Where They Stand
A wave of new MD and DO programs is reshaping U.S. medical education as the Association of American Medical Colleges warns of an 86,000‑physician shortfall by 2036. Ten schools have opened or received preliminary accreditation, many backed by health systems...
Rural Healthcare Can't Wait for AI – Here's How We're Taking Action Now
Essentia Health, serving rural Minnesota, North Dakota and Wisconsin, has equipped more than 3,000 clinicians with artificial‑intelligence tools integrated into its Epic electronic health record. By targeting five to ten high‑volume, high‑value workflows—such as automated patient‑message drafting and pre‑visit data...
Most CFOs Won’t Say This Out Loud: ‘There Is No Playbook’
Safety‑net hospitals are confronting a perfect storm of rising denial rates, soaring labor costs and looming Medicaid cuts. At the County of Santa Clara Health System, a $4 billion budget could lose roughly $1 billion annually as Medicaid funding dwindles. Deputy CFO...
Mount Sinai Estimates $50M ROI From AI Portfolio
Mount Sinai Health System projects a $50 million bottom‑line impact from its AI portfolio this year, delivering more than a 3‑to‑1 return on investment. The system unified digital and AI governance, creating a “digital AI experience portfolio” that evaluates projects against...
STAT+: Kailera’s Own ‘Triple-G’ Drug Also Looks Very Powerful
The FDA postponed its decision on AstraZeneca’s experimental breast‑cancer therapy camizestrant after advisers criticized the SERENA‑6 trial design, giving the company extra time for additional analyses. Meanwhile, Blackstone Life Sciences pledged up to $1.3 billion to Apogee Therapeutics to fund Phase 3...
From Connection to Coordination: Charting the Next Chapter of Interoperability
Healthcare leaders at a Becker’s Healthcare webinar highlighted that interoperability has moved beyond merely exchanging data to delivering usable, actionable information at the point of care. They warned that fragmented, malformed records cause clinical delays and costly duplicate testing, especially...
Influencers Are Promoting Dangerous Peptides on Social Media – and Regulators Are Struggling to Keep Up
Social media influencers are now marketing unapproved injectable peptides as quick fixes for fat loss, anti‑aging, and muscle growth, turning a niche bodybuilding product into a mainstream wellness trend. The products, often sold under “research‑only” labels, lack clinical safety data...
RFK’s Food Pyramid Is a Win for Industry, Not Health
Robert Kennedy Jr., confirmed as HHS director, has overseen a series of policy shifts that favor food and pharmaceutical industries. The administration exonerated hormone‑replacement therapy despite prior cancer and cardiovascular warnings, citing industry‑funded studies. A newly released USDA‑backed food pyramid downplays saturated‑fat...
Noom Launches $125 At-Home Biomarker Test Kit to Track HbA1c and Cardiovascular Risks for GLP-1 Users
Noom has launched a $125 at‑home biomarker test kit for its U.S. members, using the Tasso+ finger‑stick device to collect blood for a CLIA‑CAP‑certified lab. The kit measures 17 metabolic and cardiovascular markers, including HbA1c, ApoB, triglycerides, hs‑CRP and the...
Olezarsen Cuts Pancreatitis Events in Severe Hypertriglyceridemia Analysis
Swedish Orphan Biovitrum (Sobi) presented a pooled analysis of its phase 3 CORE and CORE2 trials showing that the RNA‑targeted drug olezarsen reduced acute pancreatitis events by 85% and lowered triglycerides up to 66% in patients with severe hypertriglyceridemia (baseline ≥880 mg/dL)....
Zuckerberg, Chan's Biohub Launches Protein 'World Model'
The Chan Zuckerberg Biohub has unveiled an AI‑driven "world model" for protein biology, built on an atlas of 6.8 billion proteins and 1.1 billion structures. The open‑source platform combines the ESMC language model with the ESMFold2 design engine to predict structures, design...
Information About Medications for Opioid Use Disorder (MOUD)
The FDA reports that more than 6.1 million Americans aged 12 or older are living with opioid use disorder (OUD). It highlights three FDA‑approved medications—buprenorphine, methadone and naltrexone—as core treatments and notes recent regulatory actions, including a new buprenorphine extended‑release injection...
Medicare Patients Don’t Need More Information —They Need Someone to Act
Medicare beneficiaries are not lacking information; they lack the capacity to act on it. The administrative load—long hold times, multi‑page forms, and fragmented referrals—creates an execution gap that leads to missed appointments and higher costs. Recent CMS payment reforms now...
Father Celebrates NHS Approval of Duchenne Drug Givinostat for Son
Alex, whose 12‑year‑old son Ben has Duchenne muscular dystrophy, said he is "incredibly happy" after the National Institute for Health and Care Excellence approved Givinostat for nationwide NHS use. The approval ends a 14‑month campaign to secure the drug beyond...
Psilocybin Shows Promise for Suicidal Ideation, Depression and Nerve Pain
A single 25‑mg dose of psilocybin cut chronic suicidal ideation in 70% of participants in a Sheppard Pratt trial, while separate studies reported three‑month depression relief in humans and month‑long nerve‑pain reduction in mice. Researchers say the findings could broaden...
WakeMed Declined Offer From UNC Health in Midst of Atrium Deal
WakeMed, a nonprofit health system in North Carolina, turned down an unsolicited merger proposal from UNC Health just days after announcing a planned merger with Atrium Health. Atrium, part of Advocate Health, will assume control of WakeMed and commit a...
FDA Extends Review of AstraZeneca’s Camizestrant NDA for ESR1‑Mutated Advanced Breast Cancer
The U.S. Food and Drug Administration has extended the PDUFA review date for AstraZeneca’s New Drug Application for camizestrant, an oral selective estrogen receptor degrader combined with a CDK4/6 inhibitor, after requesting more data to support its use in hormone‑receptor‑positive,...
Teladoc Health Stock Slides as Post‑Pandemic Telemedicine Demand Falters
Teladoc Health's stock continues its steep decline, with Q1 revenue slipping 2% to $613.8 million and a net loss per share improving to $0.36. The downturn reflects fading pandemic‑era demand, a 9% drop in BetterHelp revenue and users, and mounting competitive...
MediciNova Completes Phase 2 Trial of MN-001 for Diabetic NAFLD
MediciNova Inc. announced the last‑patient, last‑visit milestone for its Phase 2 MN-001‑NATG‑202 trial, evaluating tipelukast in hypertriglyceridemia and non‑alcoholic fatty liver disease (NAFLD) linked to type‑2 diabetes. The trial’s completion clears the path for data analysis and potential Phase 3...
GoodRx Launches Companion Subscription As Insurance Add-On
GoodRx introduced the Companion subscription, priced at $14.99 per month, to serve uninsured and under‑insured patients. The plan bundles access to 200 generic drugs, $19 telehealth visits, and discounted dental, vision, lab, and diagnostic services through a rented provider network....
FDA Assembles Vaccine Experts to Update COVID-19 Formulation
The FDA will convene its Vaccines and Related Biological Products Advisory Committee on May 28 to evaluate a reformulated COVID‑19 vaccine that targets the XFG subvariant, which now accounts for the majority of U.S. cases. CDC surveillance confirms XFG’s dominance,...
10 Obesity Drug Companies to Watch in 2026
Obesity drug development is diversifying beyond injectable GLP‑1s, with companies pursuing oral pills, dual/triple agonists and amylin‑based therapies. Major players such as Eli Lilly and Novo Nordisk are expanding pipelines—Lilly’s retatrutide delivered up to 28% weight loss in Phase III, while Novo’s oral...
New Drug Could Finally Stop Deadly Fatty Liver Disease
Researchers at UC San Diego reported that ION224, an antisense drug that blocks the liver enzyme DGAT2, markedly improved liver health in patients with metabolic dysfunction‑associated steatohepatitis (MASH). In a Phase IIb trial of 160 U.S. adults, the highest dose led...
FDA Delays Verdict on AZ Breast Cancer Drug
FDA has extended its review of AstraZeneca’s oral SERD camizestrant after the Oncologic Drugs Advisory Committee voted against its frontline indication. The agency requested additional analyses, including circulating tumor DNA clearance data, to evaluate long‑term efficacy. Camizestrant, which showed a...
FDA Removes Boxed Warning About Risk of Leg and Foot Amputations for the Diabetes Medicine Canagliflozin (Invokana, Invokamet, Invokamet XR)
The FDA has eliminated the boxed warning on canagliflozin (Invokana, Invokamet, Invokamet XR) that highlighted a heightened risk of leg and foot amputations. The decision follows new data from three clinical trials showing the amputation risk is lower than originally...
AI Helps Clinicians Diagnose and Treat More Effectively
Arcadia’s AI platform can mine massive healthcare data sets to spot potential misdiagnoses and detect early disease signals, according to CEO Michael Meucci. By analyzing electronic medical records, imaging, and lab results, the system flags anomalies that might otherwise be...
Making Care Plans Work Across Hospital and Neighbourhood Care
Yossi Cohen of InterSystems argues that England’s 2027 health target – 95% of people with complex needs having a care plan – can only be met by upgrading shared care records to support true cross‑organisational co‑authorship. The current rate sits...
Apogee Therapeutics Secures Up to $1.3B Financing From Blackstone to Advance Zumilokibart
Apogee Therapeutics announced a financing package of up to $1.3 billion from Blackstone, comprising roughly $800 million in synthetic royalty funding and $500 million in senior debt. The synthetic royalty agreement spans 15 years, with tiered rates that decline as sales increase and...
If the Data Center Goes Down, Patient Care Goes with It
Healthcare organizations have invested heavily in electronic records, telehealth, and imaging, but all of those clinical technologies depend on a continuously operating data center. Joe Minarik of DataBank warns that even brief outages can block access to patient records, medication...
Hospices ‘Grow Smartly’ to Strengthen Staff Retention
Hospice providers are tackling acute staffing shortages by adopting slower, strategic growth models that prioritize retention. At the ELEVATE conference, Interim HealthCare CEO Rexanne Domico emphasized building community bonds and leveraging technology to create a reputation that attracts and keeps...
New Online Toolkit Helps Clinicians Put 'Food Is Medicine' Into Practice
Tufts University’s Food is Medicine Institute launched an online Food is Medicine Toolkit to help clinicians and health‑system leaders translate nutrition research into actionable care programs. The resource, built with input from Kaiser Permanente, walks users through six stages—from program...
Therapists Turn to AI Note‑Taking Tools, Prompting Privacy and Trust Concerns
Therapists nationwide are rolling out AI‑driven note‑taking platforms that record sessions, transcribe dialogue and draft clinical notes. A patient in Arkansas says the technology left her feeling violated, while vendors argue the tools cut administrative burden and comply with HIPAA....
Updated Colorectal Cancer Guidelines Endorse New Stool Tests, Recommend Limited Use of Blood Tests
The American Cancer Society updated its colorectal cancer screening guidelines, adding a next‑generation DNA stool test and a novel RNA stool test as preferred options for average‑risk adults. Blood‑based tests are now recommended only for patients who refuse stool tests...
Virginia Unveils $553K "Beyond the Blues" Campaign to Combat Postpartum Depression
Virginia's Department of Health and Department of Behavioral Health and Developmental Services launched the "Beyond the Blues" campaign, funded with $553,000, to raise awareness of postpartum depression and provide a searchable database of support groups. The initiative aims to reduce...